In recent years, the medical community has been reevaluating traditional approaches to managing type 2 diabetes. A groundbreaking study has shed new light on ...
While these drugs are known for cardiovascular and renal benefits in type2diabetes, and GLP-1RAs also support weight loss, their use in type 1 diabetes carries significant risks. SGLT2 ...